Recruitment of Reverse Transcriptase-Cas1 Fusion Proteins by Type VI-A CRISPR-Cas Systems
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Development of the Equine Hindgut Microbiome in Semi-Feral and Domestic Conventionally-Managed Foals Meredith K
Tavenner et al. Animal Microbiome (2020) 2:43 Animal Microbiome https://doi.org/10.1186/s42523-020-00060-6 RESEARCH ARTICLE Open Access Development of the equine hindgut microbiome in semi-feral and domestic conventionally-managed foals Meredith K. Tavenner1, Sue M. McDonnell2 and Amy S. Biddle1* Abstract Background: Early development of the gut microbiome is an essential part of neonate health in animals. It is unclear whether the acquisition of gut microbes is different between domesticated animals and their wild counterparts. In this study, fecal samples from ten domestic conventionally managed (DCM) Standardbred and ten semi-feral managed (SFM) Shetland-type pony foals and dams were compared using 16S rRNA sequencing to identify differences in the development of the foal hindgut microbiome related to time and management. Results: Gut microbiome diversity of dams was lower than foals overall and within groups, and foals from both groups at Week 1 had less diverse gut microbiomes than subsequent weeks. The core microbiomes of SFM dams and foals had more taxa overall, and greater numbers of taxa within species groups when compared to DCM dams and foals. The gut microbiomes of SFM foals demonstrated enhanced diversity of key groups: Verrucomicrobia (RFP12), Ruminococcaceae, Fusobacterium spp., and Bacteroides spp., based on age and management. Lactic acid bacteria Lactobacillus spp. and other Lactobacillaceae genera were enriched only in DCM foals, specifically during their second and third week of life. Predicted microbiome functions estimated computationally suggested that SFM foals had higher mean sequence counts for taxa contributing to the digestion of lipids, simple and complex carbohydrates, and protein. -
WO 2018/064165 A2 (.Pdf)
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2018/064165 A2 05 April 2018 (05.04.2018) W !P O PCT (51) International Patent Classification: Published: A61K 35/74 (20 15.0 1) C12N 1/21 (2006 .01) — without international search report and to be republished (21) International Application Number: upon receipt of that report (Rule 48.2(g)) PCT/US2017/053717 — with sequence listing part of description (Rule 5.2(a)) (22) International Filing Date: 27 September 2017 (27.09.2017) (25) Filing Language: English (26) Publication Langi English (30) Priority Data: 62/400,372 27 September 2016 (27.09.2016) US 62/508,885 19 May 2017 (19.05.2017) US 62/557,566 12 September 2017 (12.09.2017) US (71) Applicant: BOARD OF REGENTS, THE UNIVERSI¬ TY OF TEXAS SYSTEM [US/US]; 210 West 7th St., Austin, TX 78701 (US). (72) Inventors: WARGO, Jennifer; 1814 Bissonnet St., Hous ton, TX 77005 (US). GOPALAKRISHNAN, Vanch- eswaran; 7900 Cambridge, Apt. 10-lb, Houston, TX 77054 (US). (74) Agent: BYRD, Marshall, P.; Parker Highlander PLLC, 1120 S. Capital Of Texas Highway, Bldg. One, Suite 200, Austin, TX 78746 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. -
Characterization of an Adapted Microbial Population to the Bioconversion of Carbon Monoxide Into Butanol Using Next-Generation Sequencing Technology
Characterization of an adapted microbial population to the bioconversion of carbon monoxide into butanol using next-generation sequencing technology Guillaume Bruant Research officer, Bioengineering group Energy, Mining, Environment - National Research Council Canada Pacific Rim Summit on Industrial Biotechnology and Bioenergy December 8 -11, 2013 Butanol from residue (dry): syngas route biomass → gasification → syngas → catalysis → synfuels (CO, H2, CO2, CH4) (alcohols…) Biocatalysis vs Chemical catalysis potential for higher product specificity may be less problematic when impurities present less energy intensive (low pressure and temperature) Anaerobic undefined mixed culture vs bacterial pure culture mesophilic anaerobic sludge treating agricultural wastes (Lassonde Inc, Rougemont, QC, Canada) PRS 2013 - 2 Experimental design CO Alcohols Serum bottles incubated at Next Generation RDP Pyrosequencing mesophilic temperature Sequencing (NGS) pipeline 35°C for 2 months Ion PGMTM sequencer http://pyro.cme.msu.edu/ sequences filtered CO continuously supplied Monitoring of bacterial and to the gas phase archaeal populations RDP classifier atmosphere of 100% CO, http://rdp.cme.msu.edu/ 1 atm 16S rRNA genes Ion 314TM chip classifier VFAs & alcohol production bootstrap confidence cutoff low level of butanol of 50 % Samples taken after 1 and 2 months total genomic DNA extracted, purified, concentrated PRS 2013 - 3 NGS: bacterial results Bacterial population - Phylum level 100% 80% Other Chloroflexi 60% Synergistetes % -
Reclassification of Eubacterium Hallii As Anaerobutyricum Hallii Gen. Nov., Comb
TAXONOMIC DESCRIPTION Shetty et al., Int J Syst Evol Microbiol 2018;68:3741–3746 DOI 10.1099/ijsem.0.003041 Reclassification of Eubacterium hallii as Anaerobutyricum hallii gen. nov., comb. nov., and description of Anaerobutyricum soehngenii sp. nov., a butyrate and propionate-producing bacterium from infant faeces Sudarshan A. Shetty,1,* Simone Zuffa,1 Thi Phuong Nam Bui,1 Steven Aalvink,1 Hauke Smidt1 and Willem M. De Vos1,2,3 Abstract A bacterial strain designated L2-7T, phylogenetically related to Eubacterium hallii DSM 3353T, was previously isolated from infant faeces. The complete genome of strain L2-7T contains eight copies of the 16S rRNA gene with only 98.0– 98.5 % similarity to the 16S rRNA gene of the previously described type strain E. hallii. The next closest validly described species is Anaerostipes hadrus DSM 3319T (90.7 % 16S rRNA gene similarity). A polyphasic taxonomic approach showed strain L2-7T to be a novel species, related to type strain E. hallii DSM 3353T. The experimentally observed DNA–DNA hybridization value between strain L2-7T and E. hallii DSM 3353T was 26.25 %, close to that calculated from the genomes T (34.3 %). The G+C content of the chromosomal DNA of strain L2-7 was 38.6 mol%. The major fatty acids were C16 : 0,C16 : 1 T cis9 and a component with summed feature 10 (C18 : 1c11/t9/t6c). Strain L2-7 had higher amounts of C16 : 0 (30.6 %) compared to E. hallii DSM 3353T (19.5 %) and its membrane contained phosphatidylglycerol and phosphatidylethanolamine, which were not detected in E. -
Sabnis Uta 2502D 12838.Pdf (5.069Mb)
INVESTIGATION OF HOW MICROBES INVOLVED IN ANEROBIC DIGESTION OF VINASSE CHANGE AS FUNCTIONS OF TEMPERATURE, VINASSE COMPOSITIONS AND TIME by MADHU SANJOG SABNIS Presented to the Faculty of the Graduate School of The University of Texas at Arlington in Partial Fulfillment of the Requirements for the Degree of DOCTOR OF PHILOSOPHY THE UNIVERSITY OF TEXAS AT ARLINGTON August 2014 Copyright © by Madhu Sanjog Sabnis 2014 All Rights Reserved ii Acknowledgements I would like to express my wholehearted gratitude to my advisor Dr. Melanie Sattler and Dr. Jorge Rodrigues who has always been an invaluable guide and academic mentor. I really appreciate Dr. Melanie Sattler for her encouragement, support, and advice throughout my research work. I cannot express my gratitude to Dr. Rodrigues for providing excellent ideas and advice that propelled my research. The supervising committee members Dr. James Grover, Dr. Andrew Hunt, and Dr. Sahadat Hossain, are most appreciated and gratefully acknowledged for their valuable suggestion towards this study. A special and personal acknowledgement is due to the Dr. Melanie Sattler; for her unrestricted personal guidance throughout this study, for bringing out the best out of my ability. I would like to thank Mr. Paul Shover for his tremendous help with my experimental set-up work. I also thank Shammi Rahman for helping me throughout my research. I would like to thank Victor Pylro and Jill Castoe who helped me during my experimental analysis and sequencing process. Last but not the least; I thank God and my loving family - Mom, Dad, brother, sister, and my family-in-law. They are my real strength and have always believed in my abilities to not only dream but strive to make those dreams a concrete reality. -
Effect of Fructans, Prebiotics and Fibres on the Human Gut Microbiome Assessed by 16S Rrna-Based Approaches: a Review
Wageningen Academic Beneficial Microbes, 2020; 11(2): 101-129 Publishers Effect of fructans, prebiotics and fibres on the human gut microbiome assessed by 16S rRNA-based approaches: a review K.S. Swanson1, W.M. de Vos2,3, E.C. Martens4, J.A. Gilbert5,6, R.S. Menon7, A. Soto-Vaca7, J. Hautvast8#, P.D. Meyer9, K. Borewicz2, E.E. Vaughan10* and J.L. Slavin11 1Division of Nutritional Sciences, University of Illinois at Urbana-Champaign,1207 W. Gregory Drive, Urbana, IL 61801, USA; 2Laboratory of Microbiology, Wageningen University, Stippeneng 4, 6708 WE, Wageningen, the Netherlands; 3Human Microbiome Research Programme, Faculty of Medicine, University of Helsinki, Haartmaninkatu 3, P.O. Box 21, 00014, Helsinki, Finland; 4Department of Microbiology and Immunology, University of Michigan, 1150 West Medical Center Drive, Ann Arbor, MI 48130, USA; 5Microbiome Center, Department of Surgery, University of Chicago, Chicago, IL 60637, USA; 6Bioscience Division, Argonne National Laboratory, 9700 S Cass Ave, Lemont, IL 60439, USA; 7The Bell Institute of Health and Nutrition, General Mills Inc., 9000 Plymouth Ave N, Minneapolis, MN 55427, USA; 8Division Human Nutrition, Department Agrotechnology and Food Sciences, P.O. Box 17, 6700 AA, Wageningen University; 9Nutrition & Scientific Writing Consultant, Porfierdijk 27, 4706 MH Roosendaal, the Netherlands; 10Sensus (Royal Cosun), Oostelijke Havendijk 15, 4704 RA, Roosendaal, the Netherlands; 11Department of Food Science and Nutrition, University of Minnesota, 1334 Eckles Ave, St. Paul, MN 55108, USA; [email protected]; #Emeritus Professor Received: 27 May 2019 / Accepted: 15 December 2019 © 2020 Wageningen Academic Publishers OPEN ACCESS REVIEW ARTICLE Abstract The inherent and diverse capacity of dietary fibres, nondigestible oligosaccharides (NDOs) and prebiotics to modify the gut microbiota and markedly influence health status of the host has attracted rising interest. -
Draft Genome and Description of Merdibacter Massiliensis Gen.Nov., Sp
www.nature.com/scientificreports OPEN Draft genome and description of Merdibacter massiliensis gen.nov., sp. nov., a new bacterium genus Received: 21 November 2018 Accepted: 9 May 2019 isolated from the human ileum Published: xx xx xxxx Hussein Anani1, Rita Abou Abdallah1, Nisrine Chelkha2, Anthony Fontanini2, Davide Ricaboni2, Morgane Mailhe2, Didier Raoult2,3 & Pierre-Edouard Fournier 1 We used phenotypic, genomic and phylogenetic information following the taxono-genomics approach to demonstrate that strain Marseille–P3254, isolated from an ileal sample of a 76-year old woman who underwent upper and lower digestive tract endoscopy for esophagitis and colonic polyp, is representative of a novel bacterial genus within the family Erysipelotrichaceae in the phylum Firmicutes. It is an anaerobic Gram-negative bacterium without catalase and oxidase activities. The genome of strain Marseille–P3254 is 2,468,496-bp long with a 40.1% G + C content. This new bacterium is most closely related to Eubacterium dolichum, with which it shares 90.7% 16S rRNA sequence similarity. In addition, genomic comparison using the digital DNA–DNA hybridization and OrthoANI analyses between the novel organism and the E. dolichum type strain revealed identities of 25.2 and 68.91%, respectively. The major fatty acids were C16: 0, C18: 1n9 and C18: 0. Based on these data, we propose the creation of the new genus Merdibacter gen. nov., with strain Marseille-P3254T (=CSUR P3254 = DSM 103534) being the type strain of the new species Merdibacter massiliensis gen. nov., sp. nov. A thorough knowledge of the gut microbiota composition appears essential to understand many aspects of health and diseases in humans. -
Metagenome-Wide Association of Gut Microbiome Features for Schizophrenia
ARTICLE https://doi.org/10.1038/s41467-020-15457-9 OPEN Metagenome-wide association of gut microbiome features for schizophrenia Feng Zhu 1,19,20, Yanmei Ju2,3,4,5,19,20, Wei Wang6,7,8,19,20, Qi Wang 2,5,19,20, Ruijin Guo2,3,4,9,19,20, Qingyan Ma6,7,8, Qiang Sun2,10, Yajuan Fan6,7,8, Yuying Xie11, Zai Yang6,7,8, Zhuye Jie2,3,4, Binbin Zhao6,7,8, Liang Xiao 2,3,12, Lin Yang6,7,8, Tao Zhang 2,3,13, Junqin Feng6,7,8, Liyang Guo6,7,8, Xiaoyan He6,7,8, Yunchun Chen6,7,8, Ce Chen6,7,8, Chengge Gao6,7,8, Xun Xu 2,3, Huanming Yang2,14, Jian Wang2,14, ✉ ✉ Yonghui Dang15, Lise Madsen2,16,17, Susanne Brix 2,18, Karsten Kristiansen 2,17,20 , Huijue Jia 2,3,4,9,20 & ✉ Xiancang Ma 6,7,8,20 1234567890():,; Evidence is mounting that the gut-brain axis plays an important role in mental diseases fueling mechanistic investigations to provide a basis for future targeted interventions. However, shotgun metagenomic data from treatment-naïve patients are scarce hampering compre- hensive analyses of the complex interaction between the gut microbiota and the brain. Here we explore the fecal microbiome based on 90 medication-free schizophrenia patients and 81 controls and identify a microbial species classifier distinguishing patients from controls with an area under the receiver operating characteristic curve (AUC) of 0.896, and replicate the microbiome-based disease classifier in 45 patients and 45 controls (AUC = 0.765). Functional potentials associated with schizophrenia include differences in short-chain fatty acids synth- esis, tryptophan metabolism, and synthesis/degradation of neurotransmitters. -
Abordagem Independente De Cultivo
DANIEL SAITO CARACTERIZAÇÃO DAS COMUNIDADES BACTERIANAS ASSOCIADAS ÀS INFECÇÕES ENDODÔNTICAS: ABORDAGEM INDEPENDENTE DE CULTIVO Tese apresentada à Faculdade de Odontologia de Piracicaba, da Universidade Estadual de Campinas, para obtenção do Título de Doutor em Biologia Buco-Dental, Área de Concentração Microbiologia e Imunologia. Orientador: Prof. Dr. Reginaldo Bruno Gonçalves PIRACICABA 2007 i FICHA CATALOGRÁFICA ELABORADA PELA BIBLIOTECA DA FACULDADE DE ODONTOLOGIA DE PIRACICABA Bibliotecário: Marilene Girello – CRB-8a. / 6159 Saito, Daniel. Sa28c Caracterização das comunidades bacterianas associadas às infecções endodônticas: abordagem independente de cultivo. / Daniel Saito. -- Piracicaba, SP : [s.n.], 2007. Orientador: Reginaldo Bruno Gonçalves. Tese (Doutorado) – Universidade Estadual de Campinas, Faculdade de Odontologia de Piracicaba. 1. Reação em Cadeia da Polimerase. 2. RNA Ribossômico 16S. 3. Polimorfismo de Fragmento de Restrição. I. Gonçalves, Reginaldo Bruno. II. Universidade Estadual de Campinas. Faculdade de Odontologia de Piracicaba. III. Título. (mg/fop) Título em Inglês: Characterization of bacterial communities associated with endodontic infections: culture-independent approach Palavras-chave em Inglês (Keywords): 1. Polymerase Chain Reaction. 2. 16S Ribosomal RNA. 3. Restriction Fragment Length Polymorphism. Área de Concentração: Microbiologia e Imunologia Titulação: Doutor em Biologia Buco-Dental Banca Examinadora: Marli de Fátima Fiore, Luis Eduardo Aranha Camargo, José Francisco Höfling, Sérgio Roberto Peres Line, -
The Defining Genomic and Predicted Metabolic Features of the Acetobacterium Genus
bioRxiv preprint doi: https://doi.org/10.1101/2020.01.23.904417; this version posted January 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. The defining genomic and predicted metabolic features of the Acetobacterium genus Daniel E. Ross1,2*, Christopher W. Marshall3, Djuna Gulliver1, Harold D. May4, and R. Sean Norman5 1National Energy Technology Laboratory, 626 Cochrans Mill Road, P.O. Box 10940, Pittsburgh, PA 15236-0940, USA. 2Leidos Research Support Team, 626 Cochrans Mill Road, P.O. Box 10940, Pittsburgh, PA 15236-0940, USA. 3Department of Biological Sciences, Marquette University, Milwaukee, WI, USA. 4Department of Microbiology & Immunology, Hollings Marine Laboratory, Medical University of South Carolina, Charleston, SC, USA. 5Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA. Correspondence Daniel E. Ross [email protected] bioRxiv preprint doi: https://doi.org/10.1101/2020.01.23.904417; this version posted January 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Abstract Acetogens are anaerobic bacteria capable of fixing CO2 or CO to produce acetyl-CoA and ultimately acetate using the Wood-Ljungdahl pathway (WLP). This autotrophic metabolism plays a major role in the global carbon cycle. -
Supplemental Material
Supplemental Material: Deep metagenomics examines the oral microbiome during dental caries, revealing novel taxa and co-occurrences with host molecules Authors: Baker, J.L.1,*, Morton, J.T.2., Dinis, M.3, Alverez, R.3, Tran, N.C.3, Knight, R.4,5,6,7, Edlund, A.1,5,* 1 Genomic Medicine Group J. Craig Venter Institute 4120 Capricorn Lane La Jolla, CA 92037 2Systems Biology Group Flatiron Institute 162 5th Avenue New York, NY 10010 3Section of Pediatric Dentistry UCLA School of Dentistry 10833 Le Conte Ave. Los Angeles, CA 90095-1668 4Center for Microbiome Innovation University of California at San Diego La Jolla, CA 92023 5Department of Pediatrics University of California at San Diego La Jolla, CA 92023 6Department of Computer Science and Engineering University of California at San Diego 9500 Gilman Drive La Jolla, CA 92093 7Department of Bioengineering University of California at San Diego 9500 Gilman Drive La Jolla, CA 92093 *Corresponding AutHors: JLB: [email protected], AE: [email protected] ORCIDs: JLB: 0000-0001-5378-322X, AE: 0000-0002-3394-4804 SUPPLEMENTAL METHODS Study Design. Subjects were included in tHe study if tHe subject was 3 years old or older, in good general HealtH according to a medical History and clinical judgment of tHe clinical investigator, and Had at least 12 teetH. Subjects were excluded from tHe study if tHey Had generalized rampant dental caries, cHronic systemic disease, or medical conditions tHat would influence tHe ability to participate in tHe proposed study (i.e., cancer treatment, HIV, rHeumatic conditions, History of oral candidiasis). Subjects were also excluded it tHey Had open sores or ulceration in tHe moutH, radiation tHerapy to tHe Head and neck region of tHe body, significantly reduced saliva production or Had been treated by anti-inflammatory or antibiotic tHerapy in tHe past 6 montHs. -
Thi Na Utaliblat in Un Minune Talk
THI NA UTALIBLATUS010064900B2 IN UN MINUNE TALK (12 ) United States Patent ( 10 ) Patent No. : US 10 , 064 ,900 B2 Von Maltzahn et al . ( 45 ) Date of Patent: * Sep . 4 , 2018 ( 54 ) METHODS OF POPULATING A (51 ) Int. CI. GASTROINTESTINAL TRACT A61K 35 / 741 (2015 . 01 ) A61K 9 / 00 ( 2006 .01 ) (71 ) Applicant: Seres Therapeutics, Inc. , Cambridge , (Continued ) MA (US ) (52 ) U . S . CI. CPC .. A61K 35 / 741 ( 2013 .01 ) ; A61K 9 /0053 ( 72 ) Inventors : Geoffrey Von Maltzahn , Boston , MA ( 2013. 01 ); A61K 9 /48 ( 2013 . 01 ) ; (US ) ; Matthew R . Henn , Somerville , (Continued ) MA (US ) ; David N . Cook , Brooklyn , (58 ) Field of Classification Search NY (US ) ; David Arthur Berry , None Brookline, MA (US ) ; Noubar B . See application file for complete search history . Afeyan , Lexington , MA (US ) ; Brian Goodman , Boston , MA (US ) ; ( 56 ) References Cited Mary - Jane Lombardo McKenzie , Arlington , MA (US ); Marin Vulic , U . S . PATENT DOCUMENTS Boston , MA (US ) 3 ,009 ,864 A 11/ 1961 Gordon - Aldterton et al. 3 ,228 ,838 A 1 / 1966 Rinfret (73 ) Assignee : Seres Therapeutics , Inc ., Cambridge , ( Continued ) MA (US ) FOREIGN PATENT DOCUMENTS ( * ) Notice : Subject to any disclaimer , the term of this patent is extended or adjusted under 35 CN 102131928 A 7 /2011 EA 006847 B1 4 / 2006 U .S . C . 154 (b ) by 0 days. (Continued ) This patent is subject to a terminal dis claimer. OTHER PUBLICATIONS ( 21) Appl . No. : 14 / 765 , 810 Aas, J ., Gessert, C . E ., and Bakken , J. S . ( 2003) . Recurrent Clostridium difficile colitis : case series involving 18 patients treated ( 22 ) PCT Filed : Feb . 4 , 2014 with donor stool administered via a nasogastric tube .